Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine

被引:560
作者
Mesulam, MM
Guillozet, A
Shaw, P
Levey, A
Duysen, EG
Lockridge, O
机构
[1] Northwestern Univ, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA
[2] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA
[3] Northwestern Univ, Dept Psychiat, Chicago, IL 60611 USA
[4] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA
[5] Univ Nebraska, Med Ctr, Eppley Inst, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
关键词
basal forebrain; Alzheimer's disease; cerebral cortex; striatum; choline acetyltransferase;
D O I
10.1016/S0306-4522(01)00613-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Acetylcholinesterase is one of the most prominent constituents of central cholinergic pathways. It terminates the synaptic action of acetylcholine through hydrolysis and yields the choline moiety that is necessary for transmitter recycling. Despite these pivotal relationships, mice nullizygous for acetylcholinesterase established all principal anatomical components of central cholinergic pathways. No compensatory increase in the distribution of butyrylcholinesterase was detected. However. both the wild-type and nullizygous mice showed that butyrylcholinesterase enzyme activity extended to all parts of the brain receiving cholinergic innervation and that it could hydrolyze the acetylcholine surrogate acetylthiocholine. As opposed to acetylcholinesterase which was mostly of neuronal origin, butyrylcholinesterase appeared to be mostly of glial origin. These experiments lead to the unexpected conclusion that acetylcholinesterase is not necessary for the establishment of cholinergic pathways. They also show that butyrylcholinesterase can potentially substitute for acetylcholinesterase and that this enzyme is likely to play a constitutive (rather than just back-up) role in the hydrolysis of acetylcholine in the normal brain. The inhibition of butyrylcholinesterase may therefore provide a desirable feature of cholinergic therapies, including those aimed at treating Alzheimer's disease. (C) 2002 IBRO. Published by Elsevier Science Ltd, All rights reserved.
引用
收藏
页码:627 / 639
页数:13
相关论文
共 39 条
[1]  
[Anonymous], 2000, Cholinesterases and cholinesterase inhibitors
[2]   The cholinergic deficit coincides with Aβ deposition at the earliest histopathologic stages of Alzheimer disease [J].
Beach, TG ;
Kuo, YM ;
Spiegel, K ;
Emmerling, MR ;
Sue, LI ;
Kokjohn, K ;
Roher, AE .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (04) :308-313
[3]  
Beeri R, 1997, J NEUROCHEM, V69, P2441
[4]   Compartmentation of brain glutamate metabolism in neurons and glia [J].
Daikhin, Y ;
Yudkoff, M .
JOURNAL OF NUTRITION, 2000, 130 (04) :1026S-1031S
[5]  
Darvesh S, 1998, J COMP NEUROL, V393, P374
[6]   DIFFERENTIAL LOCALIZATION OF NADPH-DIAPHORASE AND CALBINDIN-D(28K) WITHIN THE CHOLINERGIC NEURONS OF THE BASAL FOREBRAIN, STRIATUM AND BRAIN-STEM IN THE RAT, MONKEY, BABOON AND HUMAN [J].
GEULA, C ;
SCHATZ, CR ;
MESULAM, MM .
NEUROSCIENCE, 1993, 54 (02) :461-476
[7]  
Geula C, 1999, Alzheimer Disease, V2nd, P269, DOI DOI 10.1046/J.1468-1331.2000.00145.X
[8]   ACETYLCHOLINESTERASE MUTANTS IN DROSOPHILA AND THEIR EFFECTS ON THE STRUCTURE AND FUNCTION OF THE CENTRAL NERVOUS-SYSTEM [J].
GREENSPAN, RJ ;
FINN, JA ;
HALL, JC .
JOURNAL OF COMPARATIVE NEUROLOGY, 1980, 189 (04) :741-774
[9]   THE NEW STEREOLOGICAL TOOLS - DISECTOR, FRACTIONATOR, NUCLEATOR AND POINT SAMPLED INTERCEPTS AND THEIR USE IN PATHOLOGICAL RESEARCH AND DIAGNOSIS [J].
GUNDERSEN, HJG ;
BAGGER, P ;
BENDTSEN, TF ;
EVANS, SM ;
KORBO, L ;
MARCUSSEN, N ;
MOLLER, A ;
NIELSEN, K ;
NYENGAARD, JR ;
PAKKENBERG, B ;
SORENSEN, FB ;
VESTERBY, A ;
WEST, MJ .
APMIS, 1988, 96 (10) :857-881
[10]  
HERSCH SM, 1994, J NEUROSCI, V14, P3351